Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

A team of scientists at the National Institutes of Health (NIH) has developed an eye drop that successfully slowed vision ...

Researchers at the National Institutes of Health (NIH) have developed eye drops that extend vision in animal models of a ...

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...

Nanoscope Therapeutics has reported data from a mid-stage clinical trial that suggests its optogenetic therapy based on light-sensitive molecules is an effective treatment for incurable eye ...

Retinitis pigmentosa (RP) is a rare inherited condition that causes the gradual death of photoreceptors (light-sensing cells) ...

Administered via intravitreal injection, Synthopsin-MCO-010 possesses a promoter to specifically target ON-bipolar cells.

Nanoscope Therapeutics has said it plans to seek regulatory approval for its advanced retinitis pigmentosa gene therapy MCO-010 early this year.

Diabetic neuropathy refers to nerve damage that develops gradually and is caused by long-term high blood sugar levels. While there’s no cure, managing blood sugar levels can slow its progression ...